Quarterly Result21 May 2026, 01:23 pm
Krebs Biochemicals FY26: Net Loss ₹1,693.31 Lacs
AI Summary
Krebs Biochemicals & Industries Ltd's board meeting on May 21, 2026, approved the audited financial results for the year ended March 31, 2026. The company reported a net loss before tax of ₹1,693.31 lacs for the year ended March 31, 2026, compared to a loss of ₹2,692.40 lacs in the previous year. Revenue from operations stood at ₹2,373.16 lacs, down from ₹4,331.19 lacs in the previous year. The meeting commenced at 11:30 am and concluded at 1:20 pm.
Key Highlights
- Krebs Biochemicals reports a net loss before tax of ₹1,693.31 lacs for FY26.
- FY26 revenue from operations decreased to ₹2,373.16 lacs.
- Audited financial results approved by the board on May 21, 2026.
- Statutory Auditors issued an unmodified report on the financial results.
- Vizag manufacturing unit remains closed; company in dialogue with Pollution Control Board.
Price Impact
More from KREBSBIO